Smith Beth Ann bought MGNX
February 7, 2025 · Form 4 insider transaction
Smith Beth Ann bought 47,050 shares of MacroGenics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,050
Price
$0.00
Total value
N/A
InsiderSmith Beth Ann
Role—
CompanyMacroGenics, Inc. (MGNX)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2025
Filing dateFebruary 11, 2025
Shares owned after47,050
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.